ExodusPoint Capital Management »

Entrada Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $385k 37k 10.28
2025-06-30 $106k 16k 6.72
2024-12-31 $284k 17k 17.26
2024-09-30 $245k 15k 15.97

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics